Gregory Gewirtz

Gregory Gewirtz is a Partner in the Linklaters’ Mergers & Acquisitions group in New York.

Gregory’s experience includes a secondment with The Dow Chemical Company’s corporate and financial law department in Midland, Michigan. Gregory has also spent time working in Hong Kong.

Work highlights:

Gregory’s recent deal highlights include advising*:

• Volkswagen: advising on a pending $5 billion investment and electric vehicle technology joint venture with California EV manufacturer Rivian.

• The Dow Chemical Company: advising on:
  - its transaction with DuPont involving the US$130bn combination of the two companies, its subsequent separation into three publicly traded entities and the resulting US$50bn spin-off of Dow, Inc.
  - its US$5bn Reverse Morris Trust transaction with Olin.
  - its negotiations in connection with the US$17.4bn K-Dow joint venture with PIC of Kuwait and the ensuing arbitration over PIC’s refusal to close, in which Dow was awarded US$2.16bn in damages and costs.
  - its US$4.8bn strategic ownership restructuring of Dow Corning.
  - the US$1.5bn sale of its MEGlobal joint venture interest to EQUATE.
  - the US$1.63bn sale of Trinseo to Bain Capital.
  - the sale of its global polypropylene business to Braskem.
  - the sale of its interest in Nippon Unicar to the Tonen Group.
  - the sale of its acid copolymers and ionomers business to SK Global Chemical Co.
  - the sale of its extruded polystyrene foam (XPS) business.
  - the sale of its German S/A Latex business.
• Celanese: advising on:
  - its US$11bn acquisition of DuPont’s Mobility & Materials business.
  - the restructuring of its 50/50 Korea Engineering Plastics Co. joint venture with Mitsubishi Gas Chemical Company, Inc.
  - the US$1.575bn divestiture of its interest in its Polyplastics joint venture to Daicel Corporation.
  - its Nutrinova food ingredients joint venture with Mitsui.
• Lanxess: advising on:
  - its acquisition of the clean and disinfect business of Chemours.
  - its acquisition of the U.S. phosphorus additives business of Solvay.
  - its acquisition of Emerald Kalama Chemical from American Securities.
  - its acquisition of the microbial control business of IFF.
• Dover: advising on:
  - its acquisition of FW Murphy Production Controls.
  - its acquisition of Espy Corporation.
• KMG Chemicals: advising on its US$1.6bn sale to Cabot Microelectronics.
• SPX Technologies: advising on its divestiture of subsidiaries holding asbestos liabilities and related assets to a joint venture of Global Risk Capital and Premia Holdings and its related Section 251(g) reorganization.

*Includes matters handled prior to joining Linklaters.

Prior to joining Linklaters, Gregory worked as a Counsel in the M&A group of Shearman & Sterling LLP.

Gregory holds a Juris Doctor from the University of Pennsylvania. He has also obtained a Certificate in Business and Public Policy from The Wharton School at The University of Pennsylvania as well as a B.E. in Civil Engineering from The Cooper Union for the Advancement of Science and Art.

Gregory has co-authored the following publications:

• “Changing Its Mind: A Board’s Prerogative?,” The M&A Lawyer, September 2015
• “Dusting Off Appraisal Rights: The Development of a New Investment Strategy,” The M&A Lawyer, April 2014